Arylcyclohexylamines derived from BTCP are potent indirect catecholamine agonists

Add time:07/26/2019    Source:sciencedirect.com

N-[1-(2-Benzo[b]thiophenyl)cyclohexyl]piperidine (BTCP)-related molecules were prepared by means of chemical modulation of the 3 rings which constitute this dopamine (DA) and norepinephrine (NE) uptake inhibitor. Tested in vitro (binding to the DA uptake complex and to the PCP receptor sites, inhibition of the synaptosomal uptake of DA and NE) and in vivo (locomotor activity in mice) these molecules showed good homogeneity of action. The newly prepared structures, although formally related to the phencyclidine (PCP) structural model, no longer display significant affinity for the PCP receptor. These compounds behave like a new series of indirect potent stimulants of the dopaminergic and noradrenergic systems leading to potential antidepressive compounds.

We also recommend Trading Suppliers and Manufacturers of BTCP HCL (cas 112726-66-6). Pls Click Website Link as below: cas 112726-66-6 suppliers

Prev:PCP receptor and dopamine uptake sites are discriminated by chiral TCP and BTCP derivatives of opposite configuration
Next:Effect of Renzapride (cas 112727-80-7) on transit in constipation-predominant irritable bowel syndrome)